HANOVER MARC STEVEN

CIK 00012762431 companyMEMPHIS, TN

SEC Profile

Transactions

Companies

Filings

CIK

0001276243

Recent Transactions

34 trades

Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-01-01+65,000→ 65,000 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2018-01-01$12.71/sh−6,397→ 131,671 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2017-02-28+95,000→ 95,000 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2016-10-14$0.81/sh+123,456→ 1,380,680 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2016-01-26$0.65/sh+4,000→ 1,257,224 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2016-01-25$0.63/sh+12,813→ 1,253,224 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2016-01-19$0.50/sh+25,000→ 1,240,411 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2016-01-15$0.49/sh+22,100→ 1,215,411 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2016-01-14$0.47/sh+2,900→ 1,193,311 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-01-01+400,000→ 400,000 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2015-02-18+750,000→ 1,190,411 total
Award
Oncternal Therapeutics, Inc.
Common Stock Warrants (right to buy)
2014-11-14+227,273→ 227,273 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2014-11-14+227,273→ 440,411 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-09-23$0.75/sh+5,000→ 213,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-09-17$0.74/sh+10,000→ 208,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-08-21$1.00/sh+10,000→ 198,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-08-20$1.00/sh+10,000→ 188,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-08-19$1.01/sh+8,348→ 178,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-08-15$1.00/sh+1,652→ 169,790 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-08-08$0.95/sh+10,000→ 168,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-08-07$0.92/sh+20,000→ 158,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2014-08-07$0.92/sh+30,000→ 138,138 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2014-06-05+250,000→ 250,000 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2013-01-01$4.20/sh+90,000→ 90,000 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2012-01-01$3.36/sh+70,000→ 70,000 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2011-01-01$2.65/sh+70,000→ 70,000 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2010-01-01$4.20/sh+70,000→ 70,000 total
Other
Oncternal Therapeutics, Inc.
Common Stock
2009-02-19−250,000→ 352,875 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2009-01-29$10.75/sh+1,000→ 108,138 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2009-01-27$10.54/sh+2,000→ 107,138 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2009-01-01$16.84/sh+50,000→ 50,000 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2008-01-01$14.35/sh+125,000→ 125,000 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2004-11-10$11.82/sh+9,691→ 311,313 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Common Stock
2004-11-10$11.82/sh−9,691→ 41,309 total

Companies

Oncternal Therapeutics, Inc.
Director, President and COO

Recent Filings

Address

3 N. DUNLAP STREET 3RD FLOOR

MEMPHIS, TN, 38163

View on SEC.gov